2 FTSE 100 stocks I’d buy today and hold forever in a Stocks and Shares ISA

These two FTSE 100 (INDEXFTSE:UKX) shares could offer high long-term returns, in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 may be facing a period of uncertainty, due to risks such as coronavirus and geopolitical uncertainty in the US and Europe. However, there are a number of large-cap shares which appear to offer good value for money at present, due to their long-term growth potential.

With that in mind, here are two stocks that could be worth buying today through a tax-efficient account such as a Stocks and Shares ISA. They appear to have favourable long-term operating environments which may catalyse their financial performances in the coming years.

GSK

The next couple of years will be a period of significant change for GSK (LSE: GSK). Its separation into two companies could create a degree of uncertainty, which may cause investor sentiment to weaken. However, the end result is set to be a more focused biopharma company, as well as a leader in consumer healthcare.

The long-term growth potential for both businesses appears to be high. A growing, ageing world population could provide rising demand for a wide range of healthcare products. This could help to stimulate the company’s bottom line following its relatively lacklustre 1% rise in earnings in the 2020 financial year.

The stock’s price-to-earnings (P/E) ratio of 14.6 suggests it currently offers a wide margin of safety. Alongside its dividend yield of 4.6%, the company could offer the chance for investors to generate improving total returns – especially as it has the potential to become leaner and more focused as two companies. As such, now could be the right time to buy a slice of the business while it appears to offer good value for money.

Segro

Another FTSE 100 company which could have a bright long-term future is real estate investment trust (REIT) Segro (LSE: SGRO). It owns a range of warehouses across the UK and Europe which have experienced high demand from online retailers in recent years.

That trend looks set to continue, with suitable large warehouses seemingly in short supply. Segro reported in its recent quarterly update that demand for its properties has been high, and that rental growth has been buoyant. This could contribute to rising profitability over the long run, while over the next two years it’s expected to post an increase in its net profit of 8% per annum.

Segro’s price-to-book (P/B) ratio of 1.5 may be substantially higher than many of its REIT sector peers. However, its stronger financial prospects and the high demand for its properties means is could be worthy of a premium valuation. The long-term growth potential of online retailing suggests further share price growth could be ahead for the company following its 40% rise over the past year.

As such, buying it today, and holding it for the long run, could be a shrewd move.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »